Free Trial

Cytosorbents (CTSO) Competitors

Cytosorbents logo
$1.05 +0.02 (+1.94%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$1.05 0.00 (0.00%)
As of 07/8/2025 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CTSO vs. NNOX, ZIMV, SNWV, CATX, NYXH, DRTS, SMTI, BWAY, SKIN, and TCMD

Should you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Nano-X Imaging (NNOX), ZimVie (ZIMV), Sanuwave Health (SNWV), Perspective Therapeutics (CATX), Nyxoah (NYXH), Alpha Tau Medical (DRTS), Sanara MedTech (SMTI), Brainsway (BWAY), Beauty Health (SKIN), and Tactile Systems Technology (TCMD). These companies are all part of the "medical equipment" industry.

Cytosorbents vs. Its Competitors

Cytosorbents (NASDAQ:CTSO) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

32.9% of Cytosorbents shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 6.6% of Cytosorbents shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Cytosorbents had 5 more articles in the media than Nano-X Imaging. MarketBeat recorded 5 mentions for Cytosorbents and 0 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.00 beat Cytosorbents' score of -0.19 indicating that Nano-X Imaging is being referred to more favorably in the news media.

Company Overall Sentiment
Cytosorbents Neutral
Nano-X Imaging Neutral

Cytosorbents has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Cytosorbents, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cytosorbents$35.60M1.85-$20.72M-$0.28-3.75
Nano-X Imaging$11.28M26.79-$53.52M-$0.90-5.81

Cytosorbents currently has a consensus price target of $5.50, indicating a potential upside of 423.81%. Nano-X Imaging has a consensus price target of $9.50, indicating a potential upside of 81.64%. Given Cytosorbents' higher possible upside, analysts plainly believe Cytosorbents is more favorable than Nano-X Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cytosorbents
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Nano-X Imaging
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Cytosorbents has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500.

Cytosorbents has a net margin of -41.77% compared to Nano-X Imaging's net margin of -472.19%. Nano-X Imaging's return on equity of -30.92% beat Cytosorbents' return on equity.

Company Net Margins Return on Equity Return on Assets
Cytosorbents-41.77% -105.04% -29.18%
Nano-X Imaging -472.19%-30.92%-27.73%

Summary

Cytosorbents beats Nano-X Imaging on 10 of the 16 factors compared between the two stocks.

Get Cytosorbents News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTSO vs. The Competition

MetricCytosorbentsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$64.49M$10.44B$5.47B$8.95B
Dividend YieldN/A2.08%5.25%4.06%
P/E Ratio-3.7516.3327.0020.10
Price / Sales1.8530.64428.95120.24
Price / CashN/A22.7536.8257.86
Price / Book5.253.657.985.56
Net Income-$20.72M$235.43M$3.16B$248.40M
7 Day Performance5.00%1.38%2.39%4.67%
1 Month Performance-2.78%1.54%2.18%6.64%
1 Year Performance3.96%-10.04%33.82%21.31%

Cytosorbents Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTSO
Cytosorbents
1.7343 of 5 stars
$1.05
+1.9%
$5.50
+423.8%
+4.0%$64.49M$35.60M-3.75220Gap Up
NNOX
Nano-X Imaging
1.3231 of 5 stars
$5.17
-1.1%
$9.50
+83.8%
-27.1%$302.18M$11.28M-5.74190
ZIMV
ZimVie
1.9249 of 5 stars
$9.35
+1.0%
$16.33
+74.7%
-47.2%$257.87M$449.75M-13.171,770News Coverage
SNWV
Sanuwave Health
N/A$32.86
+9.7%
N/AN/A$256.24M$32.63M-7.2140
CATX
Perspective Therapeutics
1.1805 of 5 stars
$3.44
-8.5%
$12.56
+265.0%
-67.8%$255.34MN/A0.0070
NYXH
Nyxoah
N/A$7.48
+0.1%
$14.50
+93.9%
-5.8%$254.43M$4.89M-3.51110
DRTS
Alpha Tau Medical
1.8599 of 5 stars
$3.12
+4.7%
$8.00
+156.4%
+46.8%$252.76MN/A-6.7880
SMTI
Sanara MedTech
1.9378 of 5 stars
$28.39
-0.1%
$49.50
+74.4%
+9.0%$252.50M$86.67M-21.1960Positive News
BWAY
Brainsway
1.8305 of 5 stars
$13.15
-0.5%
$14.25
+8.4%
+109.3%$249.79M$41.02M65.75120
SKIN
Beauty Health
0.3395 of 5 stars
$1.91
-2.1%
$1.42
-25.8%
+9.9%$245.69M$334.30M-4.661,030
TCMD
Tactile Systems Technology
2.931 of 5 stars
$10.14
-1.9%
$16.00
+57.8%
-13.5%$240.39M$292.98M15.361,037

Related Companies and Tools


This page (NASDAQ:CTSO) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners